Robert Repella, SVP & Chief Commercial Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 107,500 shares at $12.12 ($1.3M) on 2013-11-21, disclosed to the SEC on 2013-11-21.
Open-market sale of $1.3M VNDA by SVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.07 | 2,885 | $35K | 2.7% |
| 2 | $11.89 | 40,515 | $482K | 37.2% |
| 3 | $12.12 | 64,100 | $777K | 60.1% |
| Total | $12.03 avg | 107,500 | $1.3M | 100% |